The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study. Rationale and DesignDerek C. Angus, Steven Webb, Wilma van Bentum-Puijk et al.|Annals of the American Thoracic Society|2020Cited by 449
Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19Ewan C. Goligher, Allen Cheng, Patrick R. Lawler et al.|JAMA|2023Cited by 98
Therapeutic Anticoagulation in Non-Critically Ill Patients with Covid-19Ryan Zarychanski, Patrick R. Lawler, Ewan C. Goligher et al.|medRxiv|2021Cited by 19